Familial infantile myasthenia
|
0.910 |
GeneticVariation
|
disease |
CLINVAR |
A rapid gene sequencing panel strategy to facilitate precision neonatal medicine.
|
28497657 |
2017 |
Familial infantile myasthenia
|
0.910 |
GeneticVariation
|
disease |
CLINVAR |
Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype Correlations.
|
26080897 |
2015 |
Familial infantile myasthenia
|
0.910 |
GeneticVariation
|
disease |
CLINVAR |
Functional consequences and structural interpretation of mutations of human choline acetyltransferase.
|
21786365 |
2011 |
Familial infantile myasthenia
|
0.910 |
GeneticVariation
|
disease |
BEFREE |
Clinical variability of CMS-EA (congenital myasthenic syndrome with episodic apnea) due to identical CHAT mutations in two infants.
|
15701560 |
2005 |
Familial infantile myasthenia
|
0.910 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Congenital myasthenic syndrome with episodic apnea in patients homozygous for a CHAT missense mutation.
|
12756141 |
2003 |
Familial infantile myasthenia
|
0.910 |
GeneticVariation
|
disease |
UNIPROT |
Congenital myasthenic syndrome with episodic apnea in patients homozygous for a CHAT missense mutation.
|
12756141 |
2003 |
Familial infantile myasthenia
|
0.910 |
Biomarker
|
disease |
MGD |
Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice.
|
12533614 |
2003 |
Familial infantile myasthenia
|
0.910 |
Biomarker
|
disease |
MGD |
Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferase.
|
12441053 |
2002 |
Familial infantile myasthenia
|
0.910 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans.
|
11172068 |
2001 |
Familial infantile myasthenia
|
0.910 |
GeneticVariation
|
disease |
UNIPROT |
Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans.
|
11172068 |
2001 |
Familial infantile myasthenia
|
0.910 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Familial infantile myasthenia
|
0.910 |
Biomarker
|
disease |
CTD_human |
|
|
|
Seizures
|
0.410 |
Biomarker
|
phenotype |
BEFREE |
A subset of PPT neurons exhibited reduced firing and hyperpolarization during seizures and stained positive for choline acetyltransferase.
|
30543800 |
2019 |
Seizures
|
0.410 |
Biomarker
|
phenotype |
CTD_human |
Our findings suggest that seizures caused cognitive dysfunction and a decrease of ChAT and AChE activities that might be related, at least in part, to the neurological problems presented by seizures induced by pilocarpine.
|
19941057 |
2010 |
Seizures
|
0.410 |
Biomarker
|
phenotype |
HPO |
|
|
|
Schizophrenia
|
0.330 |
Biomarker
|
disease |
BEFREE |
While more comprehensive studies are warranted to determine the precise contribution of ChAt mediated mechanisms in schizophrenia, our findings tentatively implicate a genetic influence of ChAt in the disorder's susceptibility and treatment.
|
17503482 |
2007 |
Schizophrenia
|
0.330 |
Biomarker
|
disease |
PSYGENET |
While more comprehensive studies are warranted to determine the precise contribution of ChAt mediated mechanisms in schizophrenia, our findings tentatively implicate a genetic influence of ChAt in the disorder's susceptibility and treatment.
|
17503482 |
2007 |
Schizophrenia
|
0.330 |
Biomarker
|
disease |
BEFREE |
In a previous postmortem study, we found a reduction in the density of striatal interneurons that stain immunohistochemically for choline acetyltransferase (ChAT) in schizophrenia.
|
16023618 |
2005 |
Schizophrenia
|
0.330 |
Biomarker
|
disease |
PSYGENET |
In a previous postmortem study, we found a reduction in the density of striatal interneurons that stain immunohistochemically for choline acetyltransferase (ChAT) in schizophrenia.
|
16023618 |
2005 |
Schizophrenia
|
0.330 |
Biomarker
|
disease |
BEFREE |
In addition, abnormalities of ChAT in the brain have been recently demonstrated in schizophrenia and sudden infant death syndrome.
|
10594838 |
1999 |
Angle Closure Glaucoma
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Genotype data of the 8 PACG single-nucleotide polymorphisms (SNPs) (rs11024102 at PLEKHA7, rs3753841 at COL11A1, rs1015213 located between PCMTD1 and ST18 on Chromosome 8q, rs3816415 at EPDR1, rs1258267 at CHAT, rs736893 at GLIS3, rs7494379 at FERMT2, and rs3739821 mapping in between DPM2 and FAM102A) were available.
|
31377279 |
2019 |
Angle Closure Glaucoma
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
The SNP rs3753841 in COL11A1, rs1258267 in CHAT and rs736893 in GLIS3 are associated with PACG in northern Chinese people, and the association of genetic markers manifests a tendency of ethnic diversity.
|
30399154 |
2018 |
Angle Closure Glaucoma
|
0.320 |
Biomarker
|
disease |
CTD_human |
Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma.
|
27064256 |
2016 |
Mental Depression
|
0.320 |
Biomarker
|
disease |
PSYGENET |
While our data therefore do not seem to support a major role for CHAT genetic variation in geriatric depression and AD, there might be a minor contribution in geriatric patients with depression and late onset AD, in particular those carrying the APOEε4 genotype.
|
21507424 |
2011 |
Mental Depression
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
While our data therefore do not seem to support a major role for CHAT genetic variation in geriatric depression and AD, there might be a minor contribution in geriatric patients with depression and late onset AD, in particular those carrying the APOEε4 genotype.
|
21507424 |
2011 |